Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH study)

American Journal of Cardiology

Volumn 114, Issue 5, 2014, Pages 737-742

  Maisel, Alan ^a   Xue, Yang ^a   Van Veldhuisen, Dirk J ^b   Voors, Adriaan A ^b   Jaarsma, Tiny ^c   Pang, Peter S ^d   Butler, Javed ^e   Pitt, Bertram ^f   Clopton, Paul ^a   De Boer, Rudolf A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LINKÖPING UNIVERSITY   (Sweden)

^d NORTHWESTERN UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; GALECTIN 3; PROTEIN S II; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT READMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SPIRONOLACTONE; SURVIVAL RATE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84908372824     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.05.062     Document Type: Article

References (25)

1. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M.A. Gomez-Sanchez, T. Jaarsma, L. Køber, G.Y. Lip, A.P. Maggioni, A. Parkhomenko, B.M. Pieske, B.A. Popescu, P.K. Rønnevik, F.H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P.T. Trindade, A.A. Voors, F. Zannad, A. Zeiher Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology J.J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, T. McDonagh, U. Sechtem, L.A. Bonet, P. Avraamides, H.A. Ben Lamin, M. Brignole, A. Coca, P. Cowburn, H. Dargie, P. Elliott, F.A. Flachskampf, G.F. Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J.N. Nanas, O.W. Nielsen, S. Orn, J.T. Parissis, P. Ponikowski ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
2. H. Bueno, J.S. Ross, Y. Wang, J. Chen, M.T. Vidán, S.L. Normand, J.P. Curtis, E.E. Drye, J.H. Lichtman, P.S. Keenan, M. Kosiborod, and H.M. Krumholz Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
3. T. Jaarsma, M.H. van der Wal, I. Lesman-Leegte, M.L. Luttik, J. Hogenhuis, N.J. Veeger, R. Sanderman, A.W. Hoes, W.H. van Gilst, D.J. Lok, P.H. Dunselman, J.G. Tijssen, H.L. Hillege, D.J. van Veldhuisen Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Arch Intern Med 168 2008 316 324
4. T. Jaarsma, M.H. Van Der Wal, J. Hogenhuis, I. Lesman, M.L. Luttik, N.J. Veeger, and D.J. Van Veldhuisen Design and methodology of the COACH study: a multicenter randomised Coordinating Study Evaluating Outcomes of Advising and Counselling in Heart Failure Eur J Heart Fail 6 2004 227 233
5. R.A. de Boer, D.J. Lok, T. Jaarsma, P. van der Meer, A.A. Voors, H.L. Hillege, and D.J. van Veldhuisen Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Ann Med 43 2011 60 68
6. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Gilst, A.W. Hoes, J.G. Tijssen, W.J. Paulus, A.A. Voors, and H.L. Hillege B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506
7. P. Bettencourt, A. Azevedo, J. Pimenta, F. Friões, S. Ferreira, and A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174
8. J.L. Januzzi Jr., W.F. Peacock, A.S. Maisel, C.U. Chae, R.L. Jesse, A.L. Baggish, M. O'Donoghue, R. Sakhuja, A.A. Chen, R.R. van Kimmenade, K.B. Lewandrowski, D.M. Lloyd-Jones, and A.H. Wu Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol 50 2007 607 613
9. D. Aronson, and A.J. Burger The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure J Card Fail 16 2010 541 547
10. S.L. La'ulu, F.S. Apple, M.M. Murakami, R. Ler, W.L. Roberts, and J.A. Straseski Performance characteristics of the ARCHITECT Gal-3 assay Clin Biochem 46 2013 119 122
11. B. Dieplinger, J.L. Januzzi Jr., M. Steinmair, C. Gabriel, W. Poelz, M. Haltmayer, and T. Mueller Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay Clin Chim Acta 409 2009 33 40
12. J. Hogenhuis, A.A. Voors, T. Jaarsma, H.L. Hillege, F. Boomsma, and D.J. van Veldhuisen Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP Eur J Heart Fail 7 2005 81 86
13. A. Maisel, C. Mueller, R. Nowak, W.F. Peacock, J.W. Landsberg, P. Ponikowski, M. Mockel, C. Hogan, A.H. Wu, M. Richards, P. Clopton, G.S. Filippatos, S. Di Somma, I. Anand, L. Ng, L.B. Daniels, S.X. Neath, R. Christenson, M. Potocki, J. McCord, G. Terracciano, D. Kremastinos, O. Hartmann, S. von Haehling, A. Bergmann, N.G. Morgenthaler, and S.D. Anker Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
14. W.C. Meijers, J.L. Januzzi, C. deFilippi, A.S. Adourian, S.J. Shah, D.J. van Veldhuisen, and R.A. de Boer Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials Am Heart J 167 2014 853 860.e4
15. http://www.accessdata.fda.gov/cdrh-docs/reviews/K093758.pdf.
16. R.A. Weir, I.K. Tsorlalis, T. Steedman, H.J. Dargie, R. Fraser, J.J. McMurray, and J.M. Connell Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction Eur J Heart Fail 13 2011 1305 1313
17. C.G. Brilla, G. Zhou, L. Matsubara, and K.T. Weber Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone J Mol Cell Cardiol 26 1994 809 820
18. A.D. Struthers Aldosterone: cardiovascular assault Am Heart J 144 2002 S2 S7
19. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
20. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
21. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, H. Shi, J. Vincent, S.J. Pocock, B. Pitt EMPHASIS-HF Study Group Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
22. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, C.W. Yancy American College of Cardiology Foundation American Heart Association 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in Adults a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
23. J.F. Tait, B. Little, S.A. Tait, C. Flood, and J. Bougas Splanchnic Extraction And Clearance Of Aldosterone in subjects with minimal and marked cardiac dysfunction J Clin Endocrinol Metab 25 1965 219 228
24. C. Borghi, S. Boschi, E. Ambrosioni, G. Melandri, A. Branzi, and B. Magnani Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors J Clin Pharmacol 33 1993 40 45
25. M. Yoshida, J. Ma, T. Tomita, N. Morikawa, N. Tanaka, K. Masamura, Y. Kawai, and I. Miyamori Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure Congest Heart Fail 11 2005 12 16